LH Company Profile and Key Details

Labcorp Holdings Inc. (NYSE:LH) closed at $255.06 USD, gaining $3.03 (1.20%) from the previous close of $252.03. The stock is currently mid-range between its 52-week high and low $209.38 and $293.72. With a market capitalization of about $21.14 billion, Labcorp Holdings Inc. is classified as a large-cap and shows market-like volatility (beta ~0.96). Key stats such as the average daily volume over the past year has been around 803.12 thousand shares, volume is running light vs its 52-week average. Headquartered in Burlington, NC, Labcorp Holdings Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Adam H. Schechter, the company employs approximately 60,900 people and listed since March 29, 1990. Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.

Short-term trend indicators are mixed aligned (SMA20 -3.94%, SMA50 -5.1%, SMA200 -2.13%). The stock’s 14-day RSI is 35.46 (weak momentum), while the ATR of 5.24 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -14.19% below its high and over 20.37% above its low. Average 10-day trading volume of 733.83 thousand shares is in line with the 3-month average of 766.79 thousand, indicating normal recent market interest.

Labcorp Holdings Inc. last paid a dividend of 2.88 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $382.24. This means the shares are trading below this model’s fair value.

Labcorp Holdings Inc. has 83.10 million shares outstanding. The public float is 82.66 million shares, elevated short interest at 4.30% of float. This equals 2.75 million shares. The short ratio is 3.24 days. Institutional investors hold 100.37% of the float. Insiders own 0.34%. KING DAVID P holds 312.55 thousand shares, Schechter Adam H has 87.57 thousand shares and EISENBERG GLENN A has 31.29 thousand shares. Over the past six months, insider transactions show net selling. They sold 28.40 thousand shares across 8 transactions.

Labcorp Holdings Inc. generated EPS of $10.18 over the past year. Five-year average earnings growth is 1.13%. Wall Street analysts project EPS growth of 9.48% annually over the next five years. The latest quarter delivered EPS of $3.12. The next quarter is forecast at $3.94. Next year's EPS is expected at $7.71. Analyst sentiment is bullish. Analyst rating data shows there are 8 Strong Buy ratings, 9 Buy ratings, 7 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $325.00 to $240.00. The high target offers 28.95% upside. The low target suggests -4.77% downside. The mean target is $289.17. This offers 14.74% upside. Labcorp Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended October 28, 2025, missed forecasts by -24.46%. The prior quarter beat by 4.32%. Over the last six quarters, Apple has recorded several small beats. These include -35.45% in August 01, 2024.

Labcorp Holdings Inc. (NYSE:LH) shares are flat 9.9% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Labcorp Holdings Inc. trading at a premium to the broader market with a P/E of 24.72. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $264.58, suggesting 4.98% upside. Our AI forecast model points to short-term weakness (-1.94% over two weeks), a medium-term fall (-2.16% over three months), and a longer-term gain (9.8% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Labcorp Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.94%, with price expected at $247.14 by January 02, 2026, within a range of $242.45 to $251.90 3-Month Outlook: Projected fall of -2.16%, reaching $246.59 by March 19, 2026, with a range of $244.48 to $248.76. 1-Year Outlook: Projected gain of 9.8%, with price at $276.72 by December 18, 2026, within a range of $272.69 to $281.93.

Labcorp Holdings Inc. trades at a P/E ratio of 24.72, slightly below the S&P 500 average, with a price-to-sales ratio of 1.53 and a price-to-book ratio of 2.43 suggesting the stock is closer to book value. The P/FCF stands at 15.27, also above market averages.